WebMay 10, 2024 · (RTTNews) - Bayer's (BAYZF.PK, BAYRY.PK, BYR.L) phase III study FIGARO-DKD, which evaluated the efficacy and safety of the investigational drug finerenone versus placebo when added to standard of... WebJul 14, 2024 · Mineralocorticoid receptor overactivation is thought to be a major driver of both renal and cardiac damage. Bayer also recently initiated a third study, the FINEARTS-HF study, the goal of which...

Bayer extends clinical development program for finerenone with …

WebJun 17, 2024 · The purpose of this study is to evaluate the effect of finerenone compared to placebo (a tablet without active substance) in the reduction of cardiovascular death … WebMay 10, 2024 · Bayer also recently announced the initiation of the FINEARTS-HF study, a multicenter, randomized, double-blind, placebo-controlled Phase III study which will investigate finerenone compared to placebo in more than 5,500 patients with symptomatic heart failure with a left ventricular ejection fraction of =40%. The primary objective of the … port of nawiliwili

FINEARTS - HF (Finerenone in Heart Failure Patients)

WebJun 16, 2024 · The FINEARTS-HF study will assess whether the candidateleads to a reduction in the risk of cardiovascular death and other heart failure events in patients. Finerenone (BAY 94-8862) is an ... WebFINEARTS-HF: Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) … WebContact: 443-546-1400. Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) … iron harvest trainers